Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs
1 year, 4 months ago

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs

NL Times  

The Leiden pharmaceutical company Janssen intends to largely close its vaccine department because the American parent company Johnson & Johnson wants to focus more on other, new treatment methods. In 2021, then coronavirus minister Hugo de Jonge promoted the vaccine with the slogan “Dance with Janssen.” Many young people responded. But, in the following weeks, that led to many coronavirus infections because the vaccine only worked optimally two weeks after the injection. It later emerged that the Janssen vaccine could also cause various side effects, including thrombosis.

Vaccine Janssen Leiden  cut  company  protection  leiden  vaccines  treatment  lab  johnson  shutter  weeks  wants  vaccine  coronavirus  janssen  jobs  department

History of this topic

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on
3 years, 4 months ago

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on

Hindustan Times  

Days after India's drugs regulator announced that Johnson & Johnson has pulled out its proposal seeking accelerated approval of its Covid-19 vaccine, the company said that the talks are still on. A health worker prepares a dose of Janssen Johnson & Johnson Covid-19 vaccine at Leopold Sedar Senghor stadium in Dakar, Senegal. Without giving any details, Central Drugs Standard Control …

13,000 Janssen Covid vaccine appointments canceled with new Dutch advice
3 years, 6 months ago

13,000 Janssen Covid vaccine appointments canceled with new Dutch advice

NL Times  

Approximately 13,000 people who were scheduled to receive the Janssen Covid-19 vaccine have canceled their appointments, GGD GHOR told the broadcaster NOS. It was announced on Wednesday that younger people in the Netherlands who have not yet received a Covid-19 vaccine will not be offered the Janssen vaccine. People who no longer wanted to receive this vaccine are able to …

Janssen vaccine removed from Dutch programme over blood clot fears
3 years, 6 months ago

Janssen vaccine removed from Dutch programme over blood clot fears

Dutch News  

The Leiden-developed Janssen vaccine is being removed from the Dutch vaccination programme because of fears that it can cause very rare blot clots, ministers have decided. The information currently available shows reports of problems with the vaccine in certain age groups are a similar order of magnitude to the AstraZeneca vaccine, and that there are more reports among younger people, …

Janssen vaccine removed from Dutch programme over blood clot fears
3 years, 6 months ago

Janssen vaccine removed from Dutch programme over blood clot fears

Dutch News  

The Leiden-developed Janssen vaccine is being removed from the Dutch vaccination programme because of fears that it can cause very rare blot clots, ministers have decided. The information currently available shows reports of problems with the vaccine in certain age groups are a similar order of magnitude to the AstraZeneca vaccine, and that there are more reports among younger people, …

Dutch could delay first Covid vaccine shots for many; De Jonge to discuss at press conference
3 years, 6 months ago

Dutch could delay first Covid vaccine shots for many; De Jonge to discuss at press conference

NL Times  

Many people in the Netherlands waiting for their first Covid-19 vaccine may have to wait longer due to ongoing issues with deliveries of the Janssen vaccine, Health Minister Hugo de Jonge said on Friday. De Jonge said he will address the situation in further detail at a press conference with Prime Minister Mark Rutte on Friday night. The press conference …

Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine
3 years, 7 months ago

Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine

News 18  

US pharmaceutical company Johnson and Johnson has joined hands with Telangana-based Biological E Limited for the manufacturing of the COVID-19 vaccine. We believe Biological E. will be an important part of our global COVID-19 vaccine supply network, where multiple manufacturing sites are involved in the production of our vaccine across different facilities, sometimes in different countries and continents, before the …

First Janssen coronavirus vaccine administered in Leiden
3 years, 8 months ago

First Janssen coronavirus vaccine administered in Leiden

NL Times  

Babette Engelsman, an employee of a GGZ mental healthcare facility, was the first person in the Netherlands to receive the Janssen Covid-19 vaccine. In total, five GGZ employees were to be vaccinated with the Janssen vaccine today at the museum under the eyes of Health Minister Hugo de Jonge and the Mayor of Leiden, Henri Lenferink. pic.twitter.com/PUaL6cKud3 — Hugo de …

Fears Netherlands could restrict Janssen vaccine if EMA confirms blood clot link
3 years, 8 months ago

Fears Netherlands could restrict Janssen vaccine if EMA confirms blood clot link

Dutch News  

The European Medicines Agency is expected to confirm that the Janssen coronavirus vaccine carries a low risk of thrombosis when it publishes its findings on Tuesday. The side-effects, a combination of blood clots in the cerebral vein and low platelet counts, have also been experienced by a handful of people who received the AstraZeneca vaccine. Despite the EMA concluding that …

Netherlands to start using Janssen Covid vaccine on Wednesday
3 years, 8 months ago

Netherlands to start using Janssen Covid vaccine on Wednesday

NL Times  

Health Minister Hugo de Jonge said the Netherlands will begin using the one-shot Janssen vaccine against Covid-19 beginning on Wednesday. The decision about the Janssen vaccine was made after an investigation from the European Medicines Agency's safety committee determined that the vaccine should be used even if it possibly causes an exceedingly rare side effect where blood clots form in …

EMA: Janssen Covid vaccine should be used despite "very rare" blood clots
3 years, 8 months ago

EMA: Janssen Covid vaccine should be used despite "very rare" blood clots

NL Times  

The European Medicines Agency said that the Janssen Vaccine against Covid-19 has a "possible link" to eight cases of unusual blood clots forming in patients who also presented a low platelet count. "The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of …

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks
3 years, 8 months ago

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks

Daily Mail  

Johnson & Johnson privately reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots. It comes as a pause of J&J's vaccine continues in the U.S. after multiple people developed rare, but serious, blood clots within days of receiving the shot. Johnson & Johnson privately asked other vaccine manufacturers to join …

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?
3 years, 8 months ago

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?

LA Times  

“Do no harm.” The phrase, from the Hippocratic oath, is the guiding principle of medical care. “I would characterize it as wrenching,” Vanderbilt University vaccine expert Dr. William Schaffner said of the meeting, which he attended as a nonvoting representative of the National Foundation for Infectious Diseases. In addition, many men with unusual blood clots have shown up in Europe …

J&J pitched vaccine makers industrywide probe on blood clots: WSJ
3 years, 8 months ago

J&J pitched vaccine makers industrywide probe on blood clots: WSJ

Al Jazeera  

Johnson & Johnson has reached out to other coronavirus vaccine makers to join a study on blood-clot risks, The Wall Street Journal reported Friday, citing several people familiar with the matter. Johnson & Johnson has reached out to other coronavirus vaccine makers to join a study on the risks of blood clots, The Wall Street Journal reported on Friday, citing …

Halt on Johnson & Johnson vaccine to remain while officials seek evidence
3 years, 8 months ago

Halt on Johnson & Johnson vaccine to remain while officials seek evidence

LA Times  

U.S. health officials are weighing the next steps as they investigate unusual blood clots in a six people given the Johnson & Johnson vaccine. Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after U.S. health advisors told the government Wednesday that they need more evidence to decide whether a handful of unusual blood clots were linked …

Dutch government delays Janssen Covid vaccine rollout
3 years, 8 months ago

Dutch government delays Janssen Covid vaccine rollout

NL Times  

The caretaker Cabinet of the Netherlands said it will delay use of the Janssen Covid-19 vaccine. "As soon as more is known about how the Netherlands will deal with the Janssen vaccine, these people will also receive more clarity about their vaccination," the Ministry of Health said on Wednesday. Hours earlier, the European Medicines Agency said that American pharmaceutical firm …

Janssen vaccine EU roll-out suspended because of thrombosis fears
3 years, 8 months ago

Janssen vaccine EU roll-out suspended because of thrombosis fears

Dutch News  

US pharmaceuticals group Johnson & Johnson is halting the roll-out of its Leiden-developed vaccine to Europe because of possible thrombosis-related side effects. ‘We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine,’ the company said. ‘We have been working closely …

Johnson & Johnson Covid-19 vaccine: CDC and FDA recommend US pause use of vaccine over blood clot concerns
3 years, 8 months ago

Johnson & Johnson Covid-19 vaccine: CDC and FDA recommend US pause use of vaccine over blood clot concerns

CNN  

CNN — The US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson’s Covid-19 vaccine over six reported US cases of a “rare and severe” type of blood clot. This is important, in part, to ensure that the health care provider community is …

Janssen Covid vaccine deliveries to Europe on hold over new blood clot study
3 years, 8 months ago

Janssen Covid vaccine deliveries to Europe on hold over new blood clot study

NL Times  

Deliveries of the Johnson & Johnson vaccine against Covid-19 to the European Economic Area, including the Netherlands, will be delayed as part of a new review of data to determine if the vaccine is linked to six blood clot cases in the United States. "We are aware of an extremely rare disorder involving people with blood clots in combination with …

First batch of Johnson & Johnson Covid vaccines arrive in Netherlands
3 years, 8 months ago

First batch of Johnson & Johnson Covid vaccines arrive in Netherlands

NL Times  

The first 79,200 doses of a vaccine developed in Leiden by Janssen, a pharmaceutical firm owned by Johnson and Johnson, arrived at a warehouse in Oss on Monday. The Dutch Health Council recommends that Janssen's vaccine is first given to people over 60 and those from groups at high-risk of developing serious symptoms from Covid-19. The Janssen vaccine offers 66 …

Janssen Covid vaccine arrives in NL next week amid new blood clot study
3 years, 8 months ago

Janssen Covid vaccine arrives in NL next week amid new blood clot study

NL Times  

Pharmaceutical company Janssen, a subsidiary of the US multinational Johnson & Johnson, will deliver its first doses of the coronavirus vaccine to the Netherlands on Monday. The European Medicines Agency has announced that it will investigate the drug produced in Leiden after reports of blood clots and platelet deficiency in people recently vaccinated with the Janssen vaccine, one of whom …

Johnson & Johnson COVID-19 vaccine batch fails quality check
3 years, 8 months ago

Johnson & Johnson COVID-19 vaccine batch fails quality check

Associated Press  

A batch of Johnson & Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said Wednesday. As of Wednesday, J&J had provided about 6.8 million doses to the U.S. vaccine effort, according to the Centers for Disease Control and Prevention’s online vaccine tracker. Some additional doses may not yet have been recorded as delivered, and federal …

March 31, 2021 coronavirus news
3 years, 8 months ago

March 31, 2021 coronavirus news

CNN  

Employees work in a lab at Emergent Biosolutions, which is manufacturing vaccines for AstraZeneca and Johnson & Johnson on February 8, in Baltimore, Maryland. Michael Robinson Chavez/The Washington Post/Getty Images/FILE Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its coronavirus vaccine under contract. The New York Times reported Wednesday that …

Johnson & Johnson vaccine: Quality issue at Baltimore plant delays some of the J&J supply
3 years, 8 months ago

Johnson & Johnson vaccine: Quality issue at Baltimore plant delays some of the J&J supply

CNN  

CNN — Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its single-dose coronavirus vaccine under contract. Johnson & Johnson said in a statement to CNN Wednesday that the quality control process at the plant identified “one batch” of drug substance that did not meet quality standards. On Wednesday evening, Biden …

Use Janssen Covid vaccine for medically vulnerable groups: Health Council
3 years, 9 months ago

Use Janssen Covid vaccine for medically vulnerable groups: Health Council

NL Times  

The Netherlands must first use the Johnson & Johnson vaccine, developed by Leiden subsidiary Janssen, to vaccinate medically vulnerable groups, the Health Council said in advice to Health Minister Hugo de Jonge. Once everyone in these vulnerable groups have been vaccinated, the vaccine can be used in other population groups, the Health Council said. "The vaccine protects 66 percent against …

EMA clears Leiden vaccine for use, NL has ordered 11 million doses
3 years, 9 months ago

EMA clears Leiden vaccine for use, NL has ordered 11 million doses

Dutch News  

The Amsterdam-based European Medicines Agency has cleared the coronavirus vaccine developed by Leiden based pharmaceuticals company Janssen for general use on adults. The Netherlands has ordered 11.3 million doses of the single-dose Johnson & Johnson vaccine, of which some three million doses are slated for delivery in the second quarter of the year. Two weeks after the jab, the vaccine …

Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed
3 years, 9 months ago

Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed

CNN  

CNN — Before the pandemic, Anne Leonard’s friends and family had only a cursory interest in her two decades of work manufacturing pharmaceuticals. But as President Joe Biden said Tuesday, “it simply wasn’t coming fast enough.” Biden announced that drugmaker Merck will help manufacture the Johnson & Johnson vaccine – a decision made after it became clear that J&J would …

FDA clears Johnson & Johnson’s one-dose COVID-19 vaccine shot
3 years, 9 months ago

FDA clears Johnson & Johnson’s one-dose COVID-19 vaccine shot

LA Times  

The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. The FDA said vaccine, made by Johnson & Johnson subsidiary Janssen, offers strong protection against what matters most: serious illness, hospitalizations and death. “In this environment, whatever …

EMA to approve Leiden vaccine on March 11: report
3 years, 9 months ago

EMA to approve Leiden vaccine on March 11: report

NL Times  

The European Medicines Agency will approve the Johnson & Johnson vaccine, developed with the help of Leiden pharmaceutical Janssen, on March 11, sources within the European Union told Bloomberg. A spokesperson for the EMA also told Bloomberg that the agency was discussing the Sputnik-V vaccine with Russian officials. Should research on the vaccine candidate be submitted to the EMA, its …

Johnson & Johnson vaccine: Why Americans shouldn’t turn their noses up at J&J’s coronavirus vaccine
3 years, 9 months ago

Johnson & Johnson vaccine: Why Americans shouldn’t turn their noses up at J&J’s coronavirus vaccine

CNN  

CNN — Americans are taking another look at Johnson & Johnson’s Covid-19 vaccine and its data after the vaccine received emergency use authorization by the US Food and Drug Administration on Saturday. “My big concern here is that the Johnson & Johnson is being labeled as the inferior vaccine,” said Dr. Leana Wen, a CNN medical analyst and former Baltimore …

Leiden firm's coronavirus vaccine trial to restart after patient's stroke: Report
4 years, 2 months ago

Leiden firm's coronavirus vaccine trial to restart after patient's stroke: Report

NL Times  

Testing was set to resume on a SARS-CoV-2 coronavirus vaccine developed by a laboratory in Leiden for its parent company, Johnson & Johnson, the company said in a statement. Researchers at Janssen were still being kept in the dark about whether or not the study participant who had the stroke received the vaccine or a placebo, the company said publicly. …

Coronavirus vaccine update: AstraZeneca resumes US vaccine trial, J&J to start next week
4 years, 2 months ago

Coronavirus vaccine update: AstraZeneca resumes US vaccine trial, J&J to start next week

India Today  

After being paused for over a month, AstraZeneca Plc has resumed the US trial of its experimental coronavirus vaccine after approval by regulators. AstraZeneca vaccine trials were paused in September AstraZeneca, one of the leading vaccine developers, paused its US trial on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant …

Johnson and Johnson halt their COVID-19 vaccine trial after a patient's 'unexplained illness'
4 years, 2 months ago

Johnson and Johnson halt their COVID-19 vaccine trial after a patient's 'unexplained illness'

Op India  

On Monday, Johnson & Johnson, in a statement, confirmed that it had stopped the clinical trials for the experimental one-shot Covid-19 vaccine as a study volunteer got an ‘unexplained illness’. In the press release, the company said, “We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an …

Johnson & Johnson kicks off final study of single-shot Covid vaccine in 60,000 volunteers
4 years, 3 months ago

Johnson & Johnson kicks off final study of single-shot Covid vaccine in 60,000 volunteers

India Today  

Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify the distribution of millions of doses compared with leading rivals using two doses. The company expects results of the Phase III trial by year-end or early next year, Dr Paul Stoffels, J&J's chief scientific officer, said in a joint press …

Netherlands helps secures another Covid vaccine for Europe; Developed in Leiden
4 years, 4 months ago

Netherlands helps secures another Covid vaccine for Europe; Developed in Leiden

NL Times  

The European Commission on Thursday made an agreement with Janssen Pharmaceutical about securing a possible vaccine against the coronavirus for European Union member states. The Netherlands played a leading role in the negotiations, also because Janssen is based in Leiden, the Ministry of Public Health announced. "Ultimately, we are only protected against the coronavirus if there is a vaccine," said …

Janssen Vaccines to start coronavirus trials in the Netherlands in September
4 years, 4 months ago

Janssen Vaccines to start coronavirus trials in the Netherlands in September

Dutch News  

Leiden-based pharmaceuticals company Janssen Vaccines is to start further trials of a potential coronavirus vaccine in the Netherlands, Spain and Germany in September, the company has confirmed. Janssen, part of the giant Johnson & Johnson pharmaceuticals group, has already begun trials of the vaccine in Belgium and the US, where it is quicker to get permission for human testing. ‘In …

Leiden pharma starts testing Covid vaccine on humans; Dutch can participate from Sept.
4 years, 4 months ago

Leiden pharma starts testing Covid vaccine on humans; Dutch can participate from Sept.

NL Times  

Leiden-based pharmaceutical company Janssen Vaccines started testing a potential vaccine against the coronavirus on humans. Parent company Jonson & Johnson initially expected that the so called clinical trial phase will only start in September, but a successful preclinical phase accelerated the development of the vaccine. The expanded testing in September will focus on whether smaller doses of the vaccine are …

Discover Related